[Elexacaftor,Tezacaftor和Ivacaftor:使用家庭螺旋计进行立即疗效评估]
M Thimmesch1, M Boulay2, E Defgnée2
1Unité de pneumologie pédiatrique, centre de mucoviscidose liégeois, CHC MontLégia, boulevard Patience et Beaujonc 2, 4000 Liège, Belgique.
Revue des maladies respiratoires
|January 21, 2025
概括
三重组合治疗 (Elexacaftor,Tezacaftor,Ivacaftor) 从第6天开始显著改善了囊性纤维化患者的肺功能和呼吸道症状. 发现了早期治疗的副作用,但可以通过家用螺旋计监测来控制.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
- 医疗技术 医疗技术 医学技术
背景情况:
- 囊性纤维化 (CF) 治疗通常涉及三重组合疗法,包括Elexacaftor,Tezacaftor和Ivacaftor (ETI).
- 虽然ETI的长期好处是众所周知的,但关于其最初的14天影响的详细数据有限.
研究的目的:
- 在囊性纤维化患者中研究ETI治疗在前14天的早期影响.
- 在ETI治疗的初始阶段评估肺功能和呼吸系统症状的变化.
主要方法:
- 一项前性研究,涉及20名12岁以上的CF患者开始接受ETI治疗.
- 每天在家中进行的精神测量和呼吸系统症状评分 (RSS) 记录了14天,并与患者报告的事件一起记录.
主要成果:
- 从第6天开始,FEV1 (1秒内强迫呼气量) 显著改善.
- 呼吸系统症状评分最初在第1天恶化,但从第6天开始改善. 获得了高质量的家庭螺旋测量测量 (81.2%的A级).
结论:
- 在CF患者中,ETI治疗从第6天开始显示出显著的呼吸系统益处.
- 大多数副作用发生在前四天内;每日家庭螺旋计是有价值的,但需要适当的患者培训.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Pulmonary Function Tests
297
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
297


